Search This Blog

Friday, June 20, 2025

Trump Calls For Special Counsel for 2020 Election As Texas Launches Separate Inquiry on 2024

 President Donald Trump on Friday called for a special prosecutor to investigate potential fraud in the 2020 US election

"Zero Border crossings for the month for TRUMP, verses 60,000 for Sleepy, Crooked Joe Biden, a man who lost the 2020 Presidential Election by a 'LANDSLIDE!'" Trump posted to Truth Social.

"Biden was grossly incompetent, and the 2020 election was a total FRAUD! The evidence is MASSIVE and OVERWHELMING. A Special Prosecutor must be appointed. This cannot be allowed to happen again in the United States of America! Let the work begin! What this Crooked man, and his CORRUPT CRONIES, have done to our Country in 4 years, is grossly indescribable! MAKE AMERICA GREAT AGAIN!"

The post comes on the heels of FBI reports that China allegedly mass-produced fake driver's licenses in connection with a fake ballot scheme in the 2020 election, Just the News reported. 

Officials told Just the News that U.S. Customs and Border Protection (CBP) had captured nearly 20,000 fake driver's licenses in July 2020. Those revelations have called into question the assertions from former FBI Director Christopher Wray that he knew of no foreign interference plots ahead of the election.

They have further reignited Trump's own claims of large-scale election fraud in 2020 that he has said affected the results.

Meanwhile, Texas Attorney General Ken Paxton announced on Wednesday that he's launching investigations "into 33 noncitizens for illegally voting in the 2024 election."

"Noncitizens must not be allowed to influence American elections, and I will use the full weight of my office to investigate all voter fraud," he said in a post on X. 

 

NIH Ends Gain-Of-Function Research, Implementing Trump's Executive Order

 by Savannah Hulsey Pointer via The Epoch Times,

The National Institute of Health (NIH) announced the end of gain-of-function research in a June 18 statement. The institute’s update said the move is in compliance with President Donald Trump’s executive order on the topic. 

The president’s order was issued on May 5 of this year to improve the “safety and security of biological research.” 

The agency is also suspending or terminating the awards that have supported this research, as the order requires. The awardees are required to review their research portfolios by June 30 to ensure the projects are terminated.

“NIH is requiring all NIH awardees to review their research portfolios to identify NIH funding and other support for projects meeting the definition of dangerous gain-of-function research,” the June 18 statement said

Trump’s Order 

Trump’s May executive order concludes: “Dangerous gain-of-function research on biological agents and pathogens has the potential to significantly endanger the lives of American citizens.” Additionally, the order allowed for research agencies to find and end federal funding for other biological research that “could pose a threat to American public health, public safety, or national security.”

It also ended federal funding for gain-of-function research in countries of concern, such as China and Iran, and prohibited funding from moving to foreign research that would likely cause another pandemic. 

According to the White House fact sheet, the order was given because “these measures will drastically reduce the potential for lab-related incidents involving gain-of-function research, like that conducted on bat coronaviruses in China by the EcoHealth Alliance and Wuhan Institute of Virology.”

The president’s order paused U.S. research that used infectious pathogens and toxins, citing possible danger to American citizens, until a time when a safer and more transparent plan can be implemented. 

Both COVID-19 and the 1977 Russian flu were used as illustrations of the possible outcome of underregulated research with dangerous pathogens.

House Oversight Report

In December 2024, the Republican-led House Oversight Select Subcommittee on the Coronavirus Pandemic released a 520-page report that was the end result of a two-year investigation, announcing that its findings indicated the COVID-19 virus likely originated from a laboratory in Wuhan, China.

The report found that the Wuhan Institute of Virology (WIV) was funded by the NIH and the EcoHealth Alliance Inc., which used U.S. taxpayer dollars to support the research at the lab. 

The committee said in its report that COVID-19 had biological characteristics not previously found in nature. According to the committee, the data reviewed indicated that all COVID-19 cases could be traced back to a single introduction into humans. This is different than previous pandemics, where there were multiple spillover events discovered.

“By nearly all measures of science, if there was evidence of a natural origin, it would have already surfaced,” the oversight subcommittee said in a statement.

The committee findings also cited a June 2023 Office of the Director of National Intelligence report that offered a similar conclusion, and went even further, stating, “Scientists at the WIV have created chimeras, or combinations of SARS-like coronaviruses through genetic engineering, attempted to clone other unrelated viruses, and used reverse genetic cloning techniques on SARS-like coronaviruses.”

During the investigation, the panel interviewed Anthony Fauci, former director of the National Institute of Allergy and Infectious Diseases, who left the role in December 2022. 

According to the committee report, Fauci “prompted” a research study titled “The Proximal Origin of SARS-CoV-2,” for the purpose of disproving the theory of the pandemic originating via a lab leak. 

“Although Dr. Fauci believed the lab-leak theory to be a conspiracy theory at the start of the pandemic, it now appears that his position is that he does have an open mind about the origin of the virus—so long as it does not implicate EcoHealth Alliance, and by extension himself and NIAID,” it stated, citing Fauci’s memoir that was published weeks after the hearing.

More Changes 

The Department of Health and Human Services (HHS), which governs the NIH and other agencies such as the Centers for Disease Control and Prevention, has made other significant changes. HHS Secretary Robert F. Kennedy notified the 17 members of the Advisory Committee for Immunization Practices on June 9 of their dismissal.

The panel was created by the CDC to provide advice about vaccines, including childhood and adult immunization schedules. 

Members “are knowledgeable in the fields of immunization practices and public health, have expertise in the use of vaccines and other immunobiologic agents in clinical practice or preventive medicine, have expertise with clinical or laboratory vaccine research, or have expertise in assessment of vaccine efficacy and safety,” the committee’s charter says.

Kennedy spoke to reporters about the dismissals, saying that the new members would be credentialed scientists and doctors “who are going to do evidence-based medicine, who are going to be objective, and who are going to follow the science and make critical public health determinations for our children based upon the best science.”

https://www.zerohedge.com/political/nih-ends-gain-function-research-implementing-trumps-executive-order

Genentech Combo Prolongs Remission for Relapsed or Refractory Large B-cell Lymphoma

 – Pivotal Phase III SUNMO study demonstrated an 11.5 month median progression-free survival – three times longer than R-GemOx –

– This well-tolerated investigational combination therapy avoids traditional chemotherapy and may be suitable for outpatient community care –

– Results will be submitted to global health authorities including the U.S. Food and Drug Administration –

https://finance.yahoo.com/news/genentech-lunsumio-polivy-combination-significantly-154500744.html

Argenx receives EU approval for VYVGART subcutaneous injection

 Halozyme Therapeutics, Inc. (NASDAQ: HALO), a $6.5 billion biotech, announced today that argenx has received European Commission (EC) approval for VYVGART 1000mg (efgartigimod alfa) with ENHANZE technology for subcutaneous injection in the treatment of adult patients with progressive or relapsing active chronic inflammatory demyelinating polyneuropathy (CIDP).

The approved treatment, developed using Halozyme’s proprietary recombinant human hyaluronidase enzyme (rHuPH20), is indicated for CIDP patients who have previously received corticosteroids or immunoglobulins.

According to the company, VYVGART represents the first targeted IgG Fc-antibody fragment for CIDP and introduces the first novel mechanism of action for this condition in more than three decades.

The EC approval was based on results from the ADHERE clinical trial, which the company describes as the largest study of CIDP patients to date. The approval extends to all 27 European Union member states, plus Iceland, Norway, and Liechtenstein.

The subcutaneous formulation can be administered by patients, caregivers, or healthcare professionals and is available as a vial or prefilled syringe.

"This marks another milestone in our partnership with argenx and the expansion of access to Europe is another catalyst supporting our growth," said Dr. Helen Torley, president and chief executive officer of Halozyme, in a press release statement. The company’s strong execution is reflected in its impressive 25.7% revenue growth and industry-leading 76.2% gross profit margin over the last twelve months.

Halozyme’s ENHANZE drug delivery technology is designed to facilitate subcutaneous delivery of injected drugs, potentially improving patient experience through rapid delivery and reduced treatment burden. 

https://www.investing.com/news/company-news/argenx-receives-eu-approval-for-vyvgart-subcutaneous-injection-93CH-4104308


Joe Biden’s DOJ at Work

 by John Hinderaker

We know now that Joe Biden and Merrick Garland corrupted and politicized the Department of Justice to a degree never before seen in American history. Biden’s DOJ went after the Catholic Church and parents who didn’t like what their school boards were doing, and that was shameful. But target number one for Biden’s DOJ was Biden’s biggest political rival, Donald Trump.

The Biden administration was a banana republic era in American history, in which our government weaponized law enforcement to try to imprison its most dangerous opponent.

Senator Chuck Grassley is the whistleblower’s friend, and he has done as much as anyone to expose the corruption of the Biden era. Most recently, he released a series of FBI emails in which agents plotted to try to find charges they could bring against Trump arising out the the filming of a video which January 6 protesters sang the National Anthem. Trump contributed a recitation of the Pledge of Allegiance. Biden’s FBI thought that Trump’s recitation of the Pledge might constitute a crime for which they could imprison him.

You can click through the pages here:

The New York Post interviewed Senator Grassley about these documents:

Whistleblowers have told Grassley that [FBI agent Walter] Giardina “openly stated his desire to investigate Trump, even if it meant false predication,” because of his hostility to the past and future president.

Grassley believes this email chain is another “clear example” of how the federal law enforcement apparatus was weaponized to try to “get Trump” at all costs.

“Instead of focusing on DOJ and FBI’s core law enforcement responsibilities,” Grassley told The Post, “partisan prosecutors and agents were surfing the web to find any shred of information they could use to spin another baseless case against Trump. Their actions are a disservice to Americans, who pay their salaries and depend on DOJ and FBI to keep them safe.”

The Biden era was one of both unparalleled incompetence and unparalleled corruption. It must never be allowed to happen again.

https://www.powerlineblog.com/archives/2025/06/joe-bidens-doj-at-work.php

'CNN (and Others) Issue Terrifying Warning on Soaring Microplastics. But Did They Read the Study?'

 Maybe the real story is the microscopic sample size??

A new Nature Medicine study made headlines with its claim that brain microplastics jumped 50% from 2016 to 2024. But the data are skewed — 2024 included Alzheimer’s brains, which weren’t in 2016, and they’re loaded with plastic. The real story isn’t the timeline — it’s the strong link between plastic and Alzheimer’s.
#Generated by AI

Suppose you're designing a clinical trial to determine whether people from Inner Mongolia are better or worse swimmers than those from Outer Mongolia. 

Here's your protocol: Throw 24 people from each region into the Baltic Sea for an hour. Afterward, fish out whoever’s still alive, count the bodies, and crunch the numbers.

Result: 6 Inner Mongolians drowned, while only 4 Outer Mongolians did.

Conclusion: Inner Mongolians are 50% more likely to drown. Case closed.

Not so fast. Let's look at the composition of the two groups.

  • The Inner Mongolian cohort contains eight poor swimmers, eight average swimmers, and eight good swimmers.
  • The Outer Mongolian cohort contains six poor swimmers, 10 average swimmers, and eight good swimmers. This information was not mentioned in the body of the paper. Is this a fair comparison?
  • No

What can this possibly have to do with microplastics?

More than you’d think. Because this exact kind of mismatch—more poor swimmers in one group—is called selection bias [1]. And it’s the Achilles heel of retrospective studies [2]. In the absence of closely matched groups, the result becomes unreliable, perhaps worthless.

Based on the background characteristics of the made-up study above, do you think the groups were evenly matched?  No, they're not. The Inner Mongolian cohort had more poor swimmers who are (duh) more likely to drown.

Unfortunately, the study behind the headlines, "Bioaccumulation of microplastics in decedent human brains," which was published in a recent Nature Medicine, has an important confounder, so much so that author's conclusion that there was a 50% increase in microplastics in human brains between 2016 and 2024 should be taken with a grain of polyethylene.

Was this hidden?

That's impossible to say, but to spot the bias, one has to search through the 42-page Supplemental Information section, something that is as likely to be read as a two-year-old Pennysaver. (And this is on top of a 16-page paper.) The following figures, which are found on pages 3-4, tell us what's really going on.

 

Table S1 is where the bias shows up. The first data column shows the sample from the 2016 measurement. (NM OMI means New Mexico Office of the Medical Examiner. There were 28 brains analyzed. Of a total of 28, none were brains with AD. But in 2024, the brains that were studied consisted of 24 without a diagnosis of AD, plus 12 with AD.

Why does this matter?

It matters plenty. And here is where the Mongolian Swimmers analogy comes into play. Figure 1d tells us why.

 

Figure 1d (in the paper) makes it blatantly obvious why the analogy to the Mongolian swimmers is on target. In 2016, no brains from people with AD were studied. But, in 2024, 12 of the 36 brains were from AD victims, and it is crystal clear where the bias comes from. Without exception, the brains from AD patients contain much more (5-10 times) plastic (more on this later) than those without AD. 

The blue dots represent the "bad swimmers." It becomes clear that the inclusion of AD brains is responsible for the so-called 50% increase over 8 years. All of it? Maybe. Supplement Figure 1b shows that when the AD brains are not included, a very different result arises: There is no statistically significant (p = 0.36) difference between the two groups. 

 

Supplemental Figure 1b: When AD brains are omitted from the analysis, the so-called  50% increase vanishes. This speaks volumes. 

Strengths of the study

Despite the introduction of a huge confounder, this study is both well-done and important. The following illustrates some of the highlights:

  • The group used a previously verified method at Oklahoma State called Pyrolysis–Gas Chromatography–Mass Spectrometry (Py-GC/MS) to determine the quantity of plastic in organs.
  • New Mexico samples were also analyzed at Oklahoma State, which confirmed the measurements.
  • The group generated some amazing images that visualize microplastics in tissue. Here's one example

  • Most importantly, a crystal clear link between microplastics in the brain and AD was established. Although this cannot prove that microparticles cause AD, the huge difference between the two groups shows that they may very well play a significant part in it. Remember, the presence of a chemical or substance does not speak to its potential harm.
  • This alone should cause us to pause and consider whether our use of plastics (way too much IMO) is harming us and how much (if at all). The relationship between plastics and AD is too large to ignore. 

Bottom Line

The headline-grabbing “50% increase in brain microplastics” from 2016 to 2024 doesn’t hold water. The 2024 group included 12 Alzheimer’s brains—none in 2016—and those had way more plastic. Once you take them out, the difference between the groups vanishes (p = 0.36) — a classic case of selection bias.

But here’s the thing: the study itself is excellent and important. The methods were rigorous, the measurements independently confirmed, and the analysis was thorough. Most importantly, it showed something important—brains from people with Alzheimer’s had far higher microplastic levels than those without. That finding is real, potentially huge, and absolutely worth paying attention to. The mistake was overselling the increase in the timeline; the real story is the Alzheimer’s link. 

https://www.acsh.org/news/2025/06/18/cnn-and-others-issue-terrifying-warning-soaring-microplastics-did-they-read-study

Public Health Professionals and Healthcare Providers vs. DHHS

 The recently installed leadership of the various agencies within the Department of Health & Human Services (DHHS) is surrounded by very powerful forces seeking to derail virtually everything that the Trump administration has charged them with accomplishing. The usual suspects are well known, and consist of powerful cartels that include Big Pharma, Big Food/Agriculture, Big Chemical, Big Media, and Big Tech/Data. 

Less well known are the inputs by public health professionals, healthcare providers, and the organizations that claim to represent them. As I will describe, this has caused a level of chaos and confusion within the general population that will only serve to further erode the level of trust in the medical profession, as if its reputation hasn’t taken enough of a hit over the past five years! 

I am of the belief that the Covid response disaster of the past five years, which I strongly suggested could legitimately be called a Holocaust in my previous Brownstone post, has revealed a number of other problems in healthcare that need to be examined and overhauled. I believe that the new leadership of the various agencies within DHHS is asking the right questions, and each of them has the will and the expertise to obtain answers. 

Given this state of confusion, you’d think that public health professionals, healthcare providers, and the organizations representing them would be fully onboard with the new DHHS initiatives. Sorry to say, but you’d be dead wrong! These groups have sought to derail these efforts as vigorously as the cartels. 

My years of work in public health, most prominently as a 10-year member of the NYS Dept of Health AIDS Institute Quality Advisory Committee from 2008-18, and my 19 years of rural primary care medical practice as a Board Certified internist from 1980-99 has provided me with the requisite training, knowledge, and experience to provide a roadmap as to how this destructive state of affairs came to be.

Let’s begin with the public health agencies that fall under the umbrella of DHHS. They were responsible for issuing guidance, directives, and mandates throughout the 5-year Covid pandemic response. Despite the fact that much of what these agencies did is generally known to have been based on cherry-picked or fraudulent data, and outright lies, many public health professionals still defend these actions. Here’s my take on how that happened.

The largest public health organization in the country is the American Public Health Association (APHA), of which I was a member from 2005-21. For all of those years, I was affiliated with the Alcohol, Tobacco and Other Drugs (ATOD) Section, and I gave a number of oral and poster presentations of research done at the institution where I was employed. From 2011-21, I was a member of the ATOD Program Committee, and I was charged with making sure that all ATOD oral presentations were approved for continuing education credit. 

While the ATOD Section was one of the larger sections within APHA, it seemed like it was an orphan. That’s because our section provided solid research documenting the health risks of substance use and abuse, yet most of the other sections, when given the opportunity, were solidly in favor of legalizing virtually all drugs. 

There were other areas where I personally felt like I was living in another dimension. This extended to their journal, the American Journal of Public Health (AJPH), a well-respected peer-reviewed publication. For example, Dr Fauci was treated like a rock star, and was a frequent contributor of articles. Need I say more?

Eventually, the situation became so untenable that I decided to leave APHA in 2021, and resigned from the ATOD Program Committee. Here is the letter (only slightly edited) that I sent to the Program Committee leadership:

October 29, 2021 

Now that the 2021 APHA Annual Meeting & Expo has ended, I will be stepping down from the ATOD Program Planning Committee. 

While I will no longer be actively involved in any of the month-to-month and day-to-day work of the Program Planning Committee (including abstract reviews, abstract selection, and compiling session offerings); I’ll continue to be available to answer any questions you or other members of the team may have. I believe that you have a team that is fully capable of carrying-on the work, such that the goals of ATOD for the annual meeting (compiling high quality oral and poster sessions, and obtaining CEUs for oral presentations) will continue to be met. 

My decision to step down is not due to any issues with the ATOD section, but rather with the direction of APHA in general. I’ve stated any number of times on our Zoom calls that ATOD has consistently allowed the research science to guide the political science (which is how it should be), while I’ve known for a long time of APHA’s overall left-wing bias, where, too often, political science is controlling. However, since the Biden administration assumed power; I feel that the association has become nothing but a Marxist PAC that does public health almost as an afterthought. This became most obvious when reading the COVID-related articles in AJPH. As someone with experience in direct patient care (as a Board Certified internist who provided rural primary care for 19+ years), public health (including the advisory committee of the NYS Dept of Health AIDS Institute), and clinical research; I believe I’m well qualified to know garbage when I see it. As a result, I let my APHA membership lapse.

The pandemic has also highlighted how the pharmaceutical industry has engaged in activities that are similar to the activities of the tobacco and alcohol industries that ATOD has correctly called out. Unfortunately, in the case of the pharmaceutical industry, APHA, along with other public health agencies, has shifted its stance towards the pharmaceutical industry like a weathervane, depending on the prevailing political agenda. 

I raise the foregoing issues, not out of any animus or feelings of being slighted. As a right-leaning (to say the least) conservative, I’m used to being a member of what I’ll describe as an “exclusive club” within the academic community. The reason I raise these issues is because I believe the Other Drugs members of ATOD are facing, and will continue to face, a challenge that the leadership of APHA will not touch. With the de facto open border policy that is in place in the US, the amount of fentanyl entering the country has increased to where there’s enough to kill every man, woman, and child. While drug overdose deaths decreased for the first time in at least 20 years during the 2018-19 timeframe, overdose deaths have once again increased to record levels, largely due to the influx of fentanyl. Given my belief that the APHA leadership supports having an open border, and is in favor of decriminalizing and eventually legalizing just about everything; efforts by ATOD to develop policies to address this matter in any meaningful way will hit a brick wall. In good conscience, I can’t support an association (APHA) that is of that mindset, as it is contrary to my entire work effort over the past 20 years. Further, as a grandfather of 4; these issues take on even greater urgency. 

Apologies for the length of this communication, but I believe I bring a perspective that you probably have not heard, but is worth looking at going forward. 

Thank you for the privilege of being able to serve the ATOD section for the past dozen years. 

Sincerely, 

Steve 

Steven Kritz, MD

I received responses the same day from two members of the ATOD Program Committee leadership, both of whom had previously been Program Committee chairpersons. Here’s the first response (again, only slightly edited):

October 29, 2021 

Hey Steve 

The email makes me a bit sad, but it is clear that you have given this a bunch of thought.

I want to begin by saying that your participation in the section has been an enormous contribution.

I want to thank you for saying the kind words about the section. I think that you are right—I think that the section has tried to pursue the science……we have not always gotten it right, but we have tried. 

I know that we occupy different places on the political spectrum, but you have always been deeply respectful, collegial and funny. You should know that your assistance with the opioid section of the program this past spring was a tremendous help. For reasons that I won’t get into, my bandwidth was not what it usually is and I needed the help. 

Steve- thanks very much. I have learned a ton from you over these many years that we have worked together and your commitment to quality sessions and a robust section has set a very high bar. I am deeply grateful. 

Here’s the second response (unedited):

Steve, On behalf of the ATOD Section and from me personally, I want to thank you for all that you’ve done over the years. Your dedication and depth of knowledge has been such an asset. You’re one of the reasons that we’ve consistently presented such a strong scientific program. 

I appreciate you sharing your thoughts about APHA and your willingness to answer any questions from the program committee if they come up. 

I wish you all the best. Thanks again for everything you’ve done for the ATOD Section.

From the foregoing, it should not be surprising that APHA has vigorously opposed everything that RFK, Jr. and his agency heads are trying to do. Not a week goes by that Georges Benjamin, MD, who has been Executive Director of APHA since 2002, doesn’t issue a press release warning of the deadly consequences of the work of DHHS. The recent removal of the entire FDA Advisory Committee was especially irksome to Dr Benjamin.

Let me now turn to the healthcare providers, who appear to be ignoring the current activities of DHHS. I’ll begin by stating that it looks like the worst damage from ObamaCare was that it forced virtually all practicing physicians in the country to become employees of huge healthcare organizations, with resultant loss of autonomy. I’ve come to believe that this was the government’s plan from the beginning. In other words, physicians in this country have been castrated. They do what their employers tell them to do! 

For more than a decade, I have been a regular reader of the American Journal of Medicine (AJM, AKA, The Green Journal), a well-known (at least among internists) peer-reviewed publication that is now totally online. Most articles are freely available without a subscription. In the July 2025 issue that was posted in mid-June, I read three consecutively placed articles in the Commentary section that were the true impetus for writing this article. 

The first article is entitled, Make America Healthy Again as a Clinical Practice Guideline: Let the Recommendation Classification System Speak for Itself

Here’s the first paragraph:

Something disconcerting is happening to health care and the way scientific evidence is used to guide treatment decisions in the United States (US)—the same can be said for the approach to public health. Historically, data from rigorously conducted studies, collectively forming a scientific evidence base, has been used as the primary driver for clinical decision-making and public health policy. This apolitical approach has been extremely effective in advancing medicine and public health, improving both quality of care and outcomes. It seems we have begun to deviate from a model driven by an evidence base founded on scientific inquiry. Specifically, we have entered an era of unprecedented scientific politization. It appears this new era was ushered in during the coronavirus disease 2019 (COVID-19) pandemic, where vaccine hesitancy was driven by unfounded, politically driven information that was contrary to the scientific evidence supporting vaccine safety and efficacy. This, unfortunately, led to higher COVID-19 mortality rates in US regions with lower vaccination rates, where politically motivated vaccine hesitancy was an important factor. While the US and the rest of the world have moved past the COVID-19 pandemic, the politization of science appears to have persisted, creating a new threat to medicine and public health.

The rest of this Commentary goes on to defend the development of clinical practice guidelines over the past 50 years. I’ll just paraphrase the second half of the title of this Commentary, and what any decent plaintiff attorney used to say during malpractice trials where a surgeon left a foreign object in a patient’s abdomen: Res ipsa loquitor, which means that the thing speaks for itself!

I’ll move on to the next CommentaryTurning Fate into Choice: Patient Self-Determination and Life Extension, which promotes scientific efforts to preserve life for those wishing to do so, and laments that this type of medical research is not being pursued more vigorously. Given what we have experienced with the fallout from gain-of-function research over the past several years, this Commentary seemed absolutely ghoulish. I’ll also point out that one of the authors is from Australia, where enforcement of lockdowns, social distancing, and mask mandates during the Covid pandemic were as draconian as anywhere in the world, with the possible exception of China! If this author was living in Australia during the height of the Covid pandemic, I’m willing to cut him some slack, given the toll that the country’s concentration camp environment took on everyone’s psyche.

The third and final Commentary is entitled, Los Angeles Wildfires: Getting to the Heart of It, which was co-authored by the Editor-in-Chief of AJM, a physician with whom I’ve had very pleasant email interactions over the past five years…except when I challenged an article written in January of 2022 extolling the virtues of the original Covid response, and the need to maintain those interventions. Things got a bit testy, but I decided it was better not to push too hard, so I backed off!

Here’s the first paragraph of the Commentary:

The January 2025 Los Angeles wildfires resulted in unprecedented destruction, burning nearly 60,000 acres, leveling entire neighborhoods, and claiming 29 lives. These events serve as a stark illustration of global climate change, highlighting the escalating frequency, intensity, and duration of wildfires in many regions worldwide.

The article then goes on to talk in a scholarly way about the adverse cardiac consequences of breathing in particulate matter generated by wildfires. Had the authors stuck to the healthcare issues, it would have been of value, but apparently, they couldn’t help themselves and had to enter the world of climate science, of which they clearly know very little, if anything. I guess that forest management is beyond their scope of knowledge as well, since it’s never mentioned!

In sum, public health professionals and healthcare providers in the US have been bought and paid for, and have become too willing to follow whatever shiny objects their professional organizations or paymasters place before them without question. Is it any wonder that the efforts of the new DHHS regime have been met with such fierce backlash? Going forward, those of us who recognize what’s being done need to continue supporting DHHS so that the professionals within the various agencies can put their heads down and plow ahead.

Steven Kritz, MD is a retired physician, who has been in the healthcare field for 50 years. He graduated from SUNY Downstate Medical School and completed IM Residency at Kings County Hospital. This was followed by almost 40 years of healthcare experience, including 19 years of direct patient care in a rural setting as a Board Certified Internist; 17 years of clinical research at a private-not-for-profit healthcare agency; and over 35 years of involvement in public health, and health systems infrastructure and administration activities. He retired 5 years ago, and became a member of the Institutional Review Board (IRB) at the agency where he had done clinical research, where he has been IRB Chair for the past 3 years.

https://brownstone.org/articles/public-health-professionals-and-healthcare-providers-vs-dhhs/